Amgen price target raised to $329 from $310 at Piper Sandler
Piper Sandler raised the firm’s price target on Amgen (AMGN) to $329 from $310 and keeps an Overweight rating on the shares. The firm notes the ...
Yahoo Finance10d
Amgen profits rise, next MariTide studies start by mid-year
(Reuters) - Amgen posted a higher quarterly profit on Tuesday as product sales rose 11% and said late-stage studies of key obesity drug candidate MariTide will start before mid-year but regulators ...
Amgen Profits Rise, Next MariTide Studies Start by Mid-Year
(Reuters) - Amgen posted a higher quarterly profit on Tuesday as product sales rose 11% and said late-stage studies of key ...